April 20, 2018 4:02 PM ET

Pharmaceuticals

Company Overview of PharmEste s.r.l.

OverviewBoard MembersCommittees

Key Executives for PharmEste s.r.l.

NameBoard RelationshipsTitleAge
Pier Giovanni Baraldi Ph.D.No RelationshipsFounder--
Pier Andrea Borea Ph.D.No RelationshipsFounder--
Pierangelo Geppetti M.D.No RelationshipsFounder--
Paolo Indennitate No RelationshipsChief Financial and Business Officer--
Marcello Trevisani No RelationshipsHead of Pharmacology--

PharmEste s.r.l. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Pierluigi Paracchi 4 RelationshipsGenenta Science s.r.l.--
Clive P. Page BSc, Ph.D. 19 RelationshipsPharmEste s.r.l.--
Ennio Ongini Ph.D. 18 RelationshipsNicox S.A.--
Arpad Szallasi M.D., Ph.D., FCAP 4 RelationshipsPharmEste s.r.l.--
Troels Staehelin Jensen M.D., DMSc 4 RelationshipsPharmEste s.r.l.--
View All Board Members

PharmEste s.r.l. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.
Request Profile UpdateRequest Profile Update
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
319.3K
Bonus
272.5K
Total Short Term Compensation
323.4K
Total Value of Options
10.1M
Compensation as of Fiscal Year
PharmEste s.r.l. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Canndeo Appoints Ken Charteris as Executive Director
April 12, 2018 5:15 AM ET
The Hydroponics Company Limited Appoints Henry Kinstlinger as Joint Company Secretary
April 12, 2018 5:15 AM ET
Herantis Pharma Oyj Elects Pekka Mattila as Chairman of the Board
April 11, 2018 2:00 PM ET
Earth Science Tech, Inc. Appoints Jad Nammour as the New Chief of Pharmacy
April 11, 2018 12:35 PM ET
Verona Pharma plc Announces Resignation of Kenneth Newman as Chief Medical Officer, Effective April 30, 2018
April 11, 2018 6:00 AM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact PharmEste s.r.l., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.

Close